Syndax Pharmaceuticals
SNDX
SNDX
47 hedge funds and large institutions have $102M invested in Syndax Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.07M | |
| 2 | +$1.67M | |
| 3 | +$1.22M | |
| 4 |
Jennison Associates
New York
|
+$748K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$495K |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$1.51M | |
| 3 | -$492K | |
| 4 |
Goldman Sachs
New York
|
-$353K |
| 5 |
Millennium Management
New York
|
-$328K |